Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
| Actual shortage: | 246 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2021-04-29 | 2021-05-06 | 138288 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Resolved | 2024-04-18 | 2024-05-23 | 225477 |
| TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2019-12-12 | 2020-01-25 | 101145 |
| TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118928 |
| TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125458 |
| TEVA-LENOLTEC NO. 4 | 60MG 300MG | TABLET | Resolved | 2022-01-27 | 2022-02-25 | 153724 |
| TEVA-LENOLTEC NO. 4 | 60MG 300MG | TABLET | Resolved | 2022-03-24 | 2022-05-05 | 157259 |
| TEVA-LENOLTEC NO. 4 | 60MG 300MG | TABLET | Resolved | 2023-10-05 | 2024-01-19 | 206374 |
| TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2017-08-21 | 2017-09-19 | 19968 |
| TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2020-02-07 | 2021-04-01 | 105590 |
| TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2023-02-02 | 2023-10-06 | 183404 |
| TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195833 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2021-02-25 | 2021-04-08 | 134727 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153132 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194103 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-08 | 2023-10-04 | 194106 |
| TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-19 | 2023-10-04 | 195484 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195591 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2017-03-14 | 2017-11-07 | 2297 |
| TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Resolved | 2017-04-03 | 2017-11-07 | 5207 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |